Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Blue, you could also make the argument that based on the clinical progress and pipeline of Advaxis, our valuation should be much higher than $5 today if it weren't for the self-dealing, lack of fiscal restraint and mismanagement by Dan O'Connor. So as a gesture of goodwill toward long-term shareholders who have stood by the company, extending the warrants would be a shareholder friendly nod in light of past misalignment with our interests as O'Connor used the company as his own personal piggy bank and platform for self-promotion and political networking. Berlin seems to be the man for the job, turning the company around and setting us on the right path finally, so he has nothing to do with past mismanagement, however, Sidratsky presided over the massive shareholder valuation destruction we witnessed under the O'Connor/Lombardo regimes and IMO should extend the warrants. Plus, when the stock gets back above $5 and the warrants are exercised that is more money on the company's balance sheet.